After four weeks of intensive training, Dr Yaoyao Zhang departed CN Bio Innovations , a Cambridge-based bioengineering company, ready to incorporate new technology and skills into her own research at The Pirbright Institute. Dr Zhang’s training involved learning how CN Bio’s PhysioMimix™ cell...
An enzyme called trypsin boosts the growth of infectious bronchitis virus (IBV) strains in lab cell cultures, scientists at The Pirbright Institute have shown. This finding could enable researchers to study strains of the poultry virus that were previously inaccessible and potentially provide...
In a new discovery, scientists from The Pirbright Institute confirm that cholesterol production and transport play a crucial role in how Marek’s disease virus (MDV) infects poultry cells. Researchers also found that inhibiting a protein involved in this pathway can reduce virus replication and...
A new test developed by researchers at The Pirbright Institute, in collaboration with the University of Queensland and the University of Oxford, can detect antibodies that prevent cell-to-cell fusion, a method some viruses use to infect neighbouring cells. The new test is a valuable tool for...
The Pirbright Institute will undertake two projects with ECO Animal Health Group plc (ECO) to develop vaccine candidates for porcine respiratory and reproductive syndrome virus (PRRSV). The first project is a tripartite collaboration between The Pirbright Institute, The Vaccine Group (TVG) and ECO...
Pirbright's longstanding expertise in viral diseases is helping us to provide vital services and information that will help to tackle the life changing pandemic caused by COVID-19.
Our Coronavirus Hub provides an overview of how the Institute is aiding the pandemic response, including Pirbright's COVID-19 research on vaccines, understanding how the virus works, and exploring diagnostic solutions, as well as the support we are providing to the UK diagnostic effort.
We work collaboratively with stakeholders globally, including research and academic institutions, government ministries and agencies, multilateral organisations, non-government organisations (NGOs) that range from big international charities to local advocacy groups, as well as philanthropic foundations and commercial companies.
Our innovative research into viruses of farm animals and those that spread from animals to people is possible with new state-of-the-art facilities including the BBSRC National Virology and Vaccinology Centres. Find out more about our campus.
® The Pirbright Institute 2020 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
